duoABLE for People With Stroke and Their Caregivers

October 17, 2024 updated by: University of Minnesota

duoABLE for People With Stroke and Their Caregivers (Feasibility)

The goal of this intervention study is to test whether a behavioral program that involves people with stroke and their caregivers is acceptable, safe, and can promote physically active lifestyles using enjoyable activities. Participant duos (person with stroke and their caregiver) will be asked to complete assessments at 2 timepoints, wear an activity tracker, participate in 12 sessions with an occupational therapist, and complete an interview.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • School of Kinesiology, University of Minnesota

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria (Stroke Participants):

  • Stroke diagnosed more than 6 months ago
  • Are 18 years of age or older
  • Report ≥6 hours of sedentary behavior on a typical day OR report engagement in ≤90 minutes of moderate-to-vigorous physical activity in the past week
  • Reside in a community-based setting
  • Are mobile within their home, with or without an assistive device and without physical assistance
  • Are able to identify an eligible caregiver who will engage in assessments and intervention.

Inclusion Criteria (Caregiver Participants):

  • Are 18 years of age or older
  • Report ≥6 hours of sedentary behavior on a typical day OR report engagement in ≤90 minutes of moderate-to-vigorous physical activity in the past week
  • Reside in a community-based setting
  • Are mobile within their home, with or without an assistive device and without physical assistance

Exclusion Criteria (Stroke Participants):

  • Severe aphasia
  • Are currently receiving chemotherapy or radiation treatments for cancer
  • Have a medical diagnosis of neurodegenerative disorder (i.e., dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, glioblastoma)
  • Received inpatient treatment for substance use disorder or psychiatric condition within the past 12 months
  • Have a history of skin sensitivity related to adhesives
  • Are pregnant or expecting to become pregnant in the next 2 months
  • Reside in an institutional setting
  • Are currently incarcerated

Exclusion Criteria (Caregiver Participants):

  • Have a history of skin sensitivity related to adhesives
  • Are currently receiving chemotherapy or radiation treatments for cancer
  • Have a medical diagnosis of neurodegenerative disorder (i.e., dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, glioblastoma)
  • Received inpatient treatment for substance use disorder or psychiatric condition within the past 12 months
  • Are pregnant or expecting to become pregnant in the next 2 months
  • Reside in an institutional setting
  • Are currently incarcerated

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: duoABLE
Stroke participant-caregiver duos (dyads) will meet with an occupational therapist 12 times (2x/week for 6 weeks, approximately 30 minutes/session) to apply activity monitoring, activity scheduling, collaborative problem solving, self-assessment, and social interdependence to self-selected activities that aim to increase both dyad members' physical activity levels
Stroke participant-caregiver duos (dyads) will meet with an occupational therapist 12 times (2x/week for 6 weeks, approximately 30 minutes/session) to apply activity monitoring, activity scheduling, collaborative problem solving, self-assessment, and social interdependence to self-selected activities that aim to increase both dyad members' physical activity levels

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant satisfaction
Time Frame: Score at week 8
Measured using the Client Satisfaction Questionnaire-8 (CSQ-8)
Score at week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in activity restrictions
Time Frame: Baseline to 8 weeks
Proportion of activities retained assessed at baseline and 8-weeks by the Activity Card Sort 3
Baseline to 8 weeks
Change in sedentary minutes per day
Time Frame: Baseline to 8 weeks
Minutes of sedentary time per day, measured using the activPAL micro4 (mean minutes per day determined by 7-day wear protocol) at baseline and week 8.
Baseline to 8 weeks
Change in daily step count
Time Frame: Baseline to 8 weeks
Count of steps per day, measured using the activPAL micro4 (mean daily step count determined by 7-day wear protocol) at baseline and week 8.
Baseline to 8 weeks
Change in Health-related quality of life
Time Frame: Baseline to 8 weeks
Change in score on the EuroQoL-5 Dimensions-5 Levels (EQ-5D-5L) measured at baseline and week 8
Baseline to 8 weeks
Adverse event count
Time Frame: Count of adverse events at week 8
Total count of adverse events over the course of the study based on an adverse events questionnaire completed at 8 weeks
Count of adverse events at week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emily A Kringle, PhD, OTR/L, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2023

Primary Completion (Actual)

August 24, 2024

Study Completion (Actual)

August 24, 2024

Study Registration Dates

First Submitted

July 18, 2023

First Submitted That Met QC Criteria

July 18, 2023

First Posted (Actual)

July 27, 2023

Study Record Updates

Last Update Posted (Actual)

October 21, 2024

Last Update Submitted That Met QC Criteria

October 17, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

There are no current plans to share data with other investigators. Upon the completion of the study, a de-identified dataset that includes questionnaire data, raw and processed activPAL data, and transcribed interview data will be created and stored in the DWELL Laboratory at the University of Minnesota. The PI will consider individual requests for data sharing and provide only the necessary de-identified data upon reasonable request, under a University of Minnesota data use agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Subscribe